Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 1,258 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT05139017
- Conditions
- DLBCL, Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, +10 more
- Locations
-
- Palo Verde Hematology/ Oncology Center, Ltd. ( Site 0175) Glendale, Arizona, United States
- Beverly Hills Cancer Center ( Site 0184) Beverly Hills, California, United States
- Bass Medical Group ( Site 0166) Walnut Creek, California, United States
- Innovative Clinical Research Institute ( Site 0122) Whittier, California, United States
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Infirmary Cancer Care ( Site 0157) Mobile, Alabama, United States
- Ironwood Cancer & Research Centers ( Site 0204) Chandler, Arizona, United States
- Palo Verde Cancer Specialists ( Site 0105) Glendale, Arizona, United States
- City of Hope - Phoenix ( Site 0202) Goodyear, Arizona, United States
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- USA Mitchell Cancer Institute ( Site 0173) Mobile, Alabama, United States
- Banner MD Anderson Cancer Center ( Site 0165) Gilbert, Arizona, United States
- Banner MD Anderson Cancer Center - University Medical Center Phoenix ( Site 0167) Phoenix, Arizona, United States
- The University of Arizona Cancer Center - North Campus ( Site 0124) Tucson, Arizona, United States
NCT06500273
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +13 more
- Locations
-
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- Genesis Cancer and Blood Institute Hot Springs, Arkansas, United States
- Alta Bates Summit Medical Center Berkeley, California, United States
- City of Hope Duarte, California, United States
Recruiting
A Study of Rocbrutinib in Combination With Lacutoclax in Patients With B-Cell Malignancies
NCT07609862
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +32 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, China
NCT07424833
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +33 more
- Locations
-
- Mayo Clinic Jacksonville, Florida, United States
- Henan Cancer Hospital Zhengzhou, Henan, China
- START Los Angele Los Angeles, California, United States
- START Midwest Grand Rapids, Michigan, United States
NCT07197307
- Conditions
- Aggressive Diffuse Large B-cell Lymphoma, Follicular Lymphoma (FL) Grade 3B, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- Universitätsklinikum Münster, Medizinische Klinik A Münster, Germany
- Universitaetsklinikum Aachen Aachen, Germany
- Universitaetsklinikum Augsburg Augsburg, Germany
- Vivantes Netzwerk fuer Gesundheit Berlin, Germany
NCT06785818
- Conditions
- B-Cell Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +17 more
- Locations
-
- Novartis Investigative Site Bundang Gu, Gyeonggi-do, South Korea
- Novartis Investigative Site Seongnam-si, Gyeonggi-do, South Korea
- Novartis Investigative Site Gyeonggi-do, Korea, South Korea
- Novartis Investigative Site Incheon, Korea, South Korea
Recruiting
A Study of ARC-02 in B-cell NHL
NCT07691606
- Conditions
- B-cell Non Hodgkin Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +21 more
- Locations
-
- Start Cala Los Angeles, California, United States
- Norton Cancer Institute Louisville, Kentucky, United States
- NYU Langone New York, United States
- Levine Cancer Institute Charlotte, North Carolina, United States
NCT03223610
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Diffuse Large B-cell Lymphoma, +17 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT07519772
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Colorado Blood Cancer Institute ( Site 7000) Denver, Colorado, United States
- SCRI Oncology Partners ( Site 0100) Nashville, Tennessee, United States
- Instituto Alexander Fleming ( Site 1404) Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
- Sanatorio Nuestra Senora del Rosario ( Site 1403) Rosario, Santa Fe Province, Argentina
NCT06395103
- Conditions
- B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +32 more
- Locations
-
- Children's Hospital Los Angeles ( Site 1006) Los Angeles, California, United States
- Children's Hospital Colorado-Center for Cancer and Blood Disorders ( Site 1016) Aurora, Colorado, United States
- Yale New Haven Hospital ( Site 1012) New Haven, Connecticut, United States
- Johns Hopkins All Children's Hospital ( Site 1025) St. Petersburg, Florida, United States
Recruiting
The CARDIOPROTECT Trial
NCT07654426
- Conditions
- Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +18 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
NCT07332507
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
- Locations
-
- City of Hope Comprehensive Cancer Center LAO Duarte, California, United States
Recruiting
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies
NCT05006716
- Conditions
- B-cell Malignancy, Blood Protein Disorders, Cardiovascular Diseases, +37 more
- Locations
-
- University of Alabama At Birmingham Hospital Birmingham, Alabama, United States
- Mayo Clinic Phoenix Phoenix, Arizona, United States
- Honor Health Research Institute Scottsdale, Arizona, United States
- University of Arizona Cancer Center Tucson, Arizona, United States
- Conditions
- Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Mayo Clinic - Arizona Scottsdale, Arizona, United States
- David Geffen School of Medicine at UCLA Los Angeles, California, United States
- University of California Irvine Medical Center Orange, California, United States
- University of California (UC) Davis Sacramento, California, United States
Recruiting
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
NCT04002947
- Conditions
- DLBCL, Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT06765317
- Conditions
- Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, High Grade B Cell Lymphoma, +10 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Hackensack Meridian Health (Data collection only) Hackensack, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
NCT07494565
- Conditions
- CD5 Positive, Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, +10 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
Recruiting
A Phase III Study of HMPL-760 Plus R-GemOx VS Placebo Plus R-GemOx in Relapsed/Refractory DLBCL
NCT07409428
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
- Baoding NO.1 Central Hospital Baoding, China
- Beijing GoBroad Hospital Beijing, China
- BEIJING TONGREN HOSPITAL, Capital Medical University Beijing, China